Point of Care UltraSound (POCUS) Use for Intravenous Catheter Placement During Pediatric Interfacility Transport
1 other identifier
interventional
66
0 countries
N/A
Brief Summary
This study will determine the efficacy of POCUS (Point of Care UltraSound) for intravenous (IV) access during pediatric interfacility transport. The Butterfly iQ+ (Lightning) device will be used. Children requiring IV access for transport will be randomized to POCUS-Assisted IV placement or traditional IV placement. We will examine and compare first attempt success rates with each method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2021
CompletedFirst Posted
Study publicly available on registry
May 6, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedOctober 15, 2021
October 1, 2021
1.2 years
May 3, 2021
October 7, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
First Attempt IV success rates
1 day of transfer
Secondary Outcomes (1)
Beside Times during transport
up to 24 hours
Study Arms (2)
POCUS-assisted IV placement
ACTIVE COMPARATORusing ultrasound to help with placement
Traditional IV placement
ACTIVE COMPARATORStandard of care
Interventions
ultrasound will be used in the intervention group for IV access
ultrasound will not be used in the traditional IV placement group
Eligibility Criteria
You may qualify if:
- Pediatric patients requiring IV access prior to transport by the Angel One Transport Team back to Arkansas Children's Hospital
- Age group: 2 weeks - 18 years
You may not qualify if:
- Adequate IV Access
- NICU transports
- Patients not needing IV access
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Michael H Stroud, MD
University of Arkansas
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2021
First Posted
May 6, 2021
Study Start
October 1, 2021
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
October 15, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share